Cancer Research The Future of Cancer Research: Science and Patient Impact
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 55, 2316-2324, June 1, 1995]
© 1995 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Smith, B. A.
Right arrow Articles by Beland, F. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Smith, B. A.
Right arrow Articles by Beland, F. A.

DNA Adduct Formation and T-Lymphocyte Mutation Induction in F344 Rats Implanted with Tumorigenic Doses of 1,6-Dinitropyrene1

Beverly A. Smith, Nancy F. Fullerton, Robert H. Heflich and Frederick A. Beland2

National Center for Toxicological Research, Jefferson, Arkansas 72079

Diesel emissions are known to induce tumors in experimental animals and are suspected of being carcinogenic in humans. Of the compounds associated with diesel exhaust, 1,6-dinitropyrene is a particularly potent mutagen and carcinogen. In these experiments, we have investigated the use of DNA adducts and T-lymphocyte mutations of 1,6-dinitropyrene as biomarkers for exposure to diesel emissions. 1,6-Dinitropyrene (0–150 µg) was applied directly to the lungs of male F344 rats according to a protocol known to induce lung tumors. In target (lung) and surrogate (liver, WBC, and spleen lymphocytes) tissues, one major DNA adduct, N-(deoxyguanosin-8-yl)-1-amino-6-nitropyrene, was detected by HPLC and/or 32P-post-labeling analyses. The levels of this adduct reached a maximum 1–7 days following treatment and decreased to 13–50% of the peak values by 28 days after dosing. In the lung, a 2-fold increase in dose resulted in a 2-fold increase in DNA binding up to the 30-µg dose; in the liver the same relationship was observed up to 10 µg 1,6-dinitropyrene. At higher doses, the extent of adduct formation still increased, but the rate was much lower than that occurring at lower doses. A limiting dilution clonal assay was used to measure mutation induction at the hypoxanthine-guanine phosphoribosyltransferase locus in spleen T lymphocytes. Following treatment, the mutant frequency increased until 21 weeks, remained constant until week 40, and then began to decrease. Mutant induction was dose related, with the increase in mutant frequency being significant at doses ≥1 µg 1,6-dinitropyrene. These data indicate that 1,6-dinitropyrene, a constituent of diesel emissions, is metabolically activated by nitroreduction to give DNA adducts in target and surrogate tissues. They further suggest that T-lymphocyte mutations may be a more sensitive and longer-lived biomarker than DNA adducts for assessing previous exposures to nitropolycyclic aromatic hydrocarbons.

1 Part of the research described in this article was conducted under contract to the Health Effects Institute, an organization jointly funded by the United States Environmental Protection Agency under Assistance Agreement X812059 and automotive manufacturers. The contents of this article do not necessarily reflect the views of the Health Effects Institute, nor do they necessarily reflect the policies of the Environmental Protection Agency or automotive manufacturers. Preliminary accounts of this work have appeared in Environ. Health Perspect. 99: 277–280, 1993 and 102 (Suppl 6): 185–189, 1994.

2 To whom requests for reprints should be addressed, at HFT-110, National Center for Toxicological Research, 3900 NCTR Road, Jefferson, AR 72079.

Received 1/ 9/95. Accepted 3/31/95.




This article has been cited by other articles:


Home page
CarcinogenesisHome page
C. A. Bieler, M. G. Cornelius, M. Stiborova, V. M. Arlt, M. Wiessler, D. H. Phillips, and H. H. Schmeiser
Formation and persistence of DNA adducts formed by the carcinogenic air pollutant 3-nitrobenzanthrone in target and non-target organs after intratracheal instillation in rats
Carcinogenesis, May 1, 2007; 28(5): 1117 - 1121.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
E. Nagy, M. Zeisig, K. Kawamura, Y. Hisamatsu, A. Sugeta, S. Adachi, and L. Moller
DNA adduct and tumor formations in rats after intratracheal administration of the urban air pollutant 3-nitrobenzanthrone
Carcinogenesis, October 1, 2005; 26(10): 1821 - 1828.
[Abstract] [Full Text] [PDF]


Home page
Toxicol PatholHome page
M. D. Boudreau, D. G. Baker, H. W. Taylor, S. A. Barker, and J. C. Means
Suppression of Arylamine Toxicity in the Fischer-344 Rat Following Ingestion of a Complex Mixture
Toxicol Pathol, April 1, 2001; 29(3): 333 - 343.
[Abstract] [PDF]


Home page
CarcinogenesisHome page
T. Chen, A. Aidoo, R. A. Mittelstaedt, D. A. Casciano, and R. H. Heflich
Hprt mutant frequency and molecular analysis of Hprt mutations in Fischer 344 rats treated with thiotepa
Carcinogenesis, February 1, 1999; 20(2): 269 - 277.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1995 by the American Association for Cancer Research.